Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06141850 · ClinicalTrials.gov registry record · NA
Promoting Engagement and COVID-19 Testing for Health
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 290
- Enrollment target
NCT06141850 is a NA study that has completed, run by Emory University. The registered enrollment target is 290 participants.
The verdict
NCT06141850, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 290 participants
- Enrollment target
Study Summary
PEACH2 is a community-based study, targeting individuals affected by diabetes. Study participants will be randomized into the PEACH2 Intervention Arm or the Control Arm. The intervention lasts for 16 weeks and participants will be followed for 12 months in total.
Interventions
- BEHAVIORAL COVID-19 Test Reporting
- BEHAVIORAL Personalized Nudges via Text Messaging
- BEHAVIORAL Non-personalized Nudges via Text Messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2023-12-06 |
| Est. Completion | 2025-03-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06141850
The ClinicalTrials.gov registry entry for NCT06141850 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which COVID-19 Test Reporting is the first listed.
NCT06141850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06141850 about?
NCT06141850 is a clinical study titled "Promoting Engagement and COVID-19 Testing for Health". PEACH2 is a community-based study, targeting individuals affected by diabetes. Study participants will be randomized into the PEACH2 Intervention Arm or the Control Arm. The intervention lasts for 16 weeks and participants will be followed for 12 months in total.
What is the current status of trial NCT06141850?
This trial is currently completed. It is a NA study. The enrollment target is 290 participants. The study started on 2023-12-06. Estimated completion is 2025-03-25.
What interventions are being tested in trial NCT06141850?
The interventions under investigation include: COVID-19 Test Reporting (BEHAVIORAL), Personalized Nudges via Text Messaging (BEHAVIORAL), Non-personalized Nudges via Text Messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT06141850?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.